FMP
Miromatrix Medical Inc.
MIRO
NASDAQ
Inactive Equity
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
3.39 USD
0.02 (0.59%)
About
ceo
Dr. Jeffrey James Ross Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.miromatrix.com
exchange
NASDAQ
Description
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
CIK
0001527096
ISIN
US60471P1084
CUSIP
60471P108
Address
6455 Flying Cloud Drive
Phone
952 942 6000
Country
US
Employee
76
IPO Date
Jun 24, 2021
Summary
CIK
0001527096
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
60471P108
ISIN
US60471P1084
Country
US
Price
3.39
Beta
0.01
Volume Avg.
163.02k
Market Cap
92.95M
Shares
-
52-Week
0.906-4.35
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.97
P/B
-
Website
https://www.miromatrix.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest MIRO News
It looks like there's no news available.
